Lugli AP, Gori N, Ippoliti E, Ambrosio B, Peris K. Upadacitinib as a potential option for the management of paradoxical eczema induced by interleukin-23 inhibitors. Dermatol Reports [Internet]. 2026 Feb. 3 [cited 2026 May 25];. Available from: https://journals.pagepress.net/dr/article/view/10644